Josh Hamermesh, MBA
Senior Vice President, Business Development
Josh Hamermesh is the Senior Vice President, Business Development at Centessa Pharmaceuticals. He brings more than two decades of experience in corporate strategy, business development and commercialization for pharmaceutical and biotechnology companies to his role. Prior to joining Centessa, Josh served as Chief Business Office of Gamida Cell Ltd., where he was responsible for Gamida Cell’s business development, strategic financing, investor relations and corporate communications activities. Before Gamida Cell, Josh served as Senior Vice President at Locust Walk Partners, Inc., a strategic partnering and financing transaction advisory firm, where he played an instrumental role in leading numerous transactions across an array of therapeutic areas and technologies. Josh has also held senior business development and executive leadership positions at Infinity Pharmaceuticals, Inc., Pervasis Therapeutics, Inc., Molecular Insight Pharmaceuticals, Inc., Genzyme Corporation and MG Biotherapeutics LLC.
Josh is currently a member of the Board of Directors at LiPac Oncology, LLC, and Neurohealing Pharmaceuticals, Inc. He holds a B.S., magna cum laude, from Amherst College and an MBA from Harvard Business School.